학술논문

Sample size determination in Bayesian clinical trials: inferential performance-based approach using two priors
Document Type
Journal Article
Source
Japanese Journal of Biometrics. 2023, 44(1):35
Subject
Bayesian power function
clinical trials
performance-based sample size determination
preposterior analysis
two-priors approach
Language
English
ISSN
0918-4430
2185-6494
Abstract
Determination of the number of subjects to include in a clinical trial is a crucial aspect of experimental design. The standard methodology for sample size determination (SSD) has been established based on a frequentist perspective, while the literature addressing the SSD problem from a Bayesian perspective has increased for the last 20 years. In this paper I discuss the basic concept of Bayesian SSD, with specific focus on an inferential performance-based (non-decision theoretic) approach, using two distinct prior distributions: analysis prior and design prior. The analysis prior formalizes pre-trial information, and it is used to obtain posterior distributions, while the design prior describes a scenario and it is used to obtain prior predictive distributions. In practice, the specification of prior distributions is a key element of Bayesian inference. The prior information may be derived from either expert beliefs or relevant empirical data, and the subjective knowledge derived from an expert elicitation procedure may be useful to define a prior distribution when no or limited data from previous studies is available. In experimental design, the interplay between Bayesian and frequentist methodology is intrinsic. Whichever method is used in SSD, the distinction between demands as expressed in the range of equivalence, and their expectation or beliefs, as represented by the prior information is of paramount importance.